The Plasma Separation System Market is expanding as healthcare systems respond to rising demand for plasma-derived products, advanced blood processing technologies, and efficient separation solutions. The market was valued at USD 22.96 billion in 2023 and USD 25.33 billion in 2024, with projections indicating growth to approximately USD 55.6 billion by 2032 at a CAGR of 10.32%.
Increasing demand for plasma-based therapies is one of the major factors supporting market expansion. Plasma-derived products are used across a range of healthcare applications, while the growing prevalence of chronic diseases is encouraging continued investment in plasma collection, processing, and fractionation capabilities.
Technological development is also influencing the competitive landscape. Automated plasma separation systems are gaining attention because they can support greater efficiency and consistency in blood banks and plasma fractionation facilities. Advances in filtration, apheresis, and other separation techniques are further broadening the range of applications available to healthcare and research organizations.
Centrifugation remains the leading separation technique, accounting for more than 60% of global market revenue in 2024, according to the report. Filtration and apheresis are also expected to gain importance as organizations seek more efficient and specialized separation capabilities.
The outlook remains positive as governments, healthcare institutions, biotechnology companies, and medical technology manufacturers continue investing in plasma-related infrastructure. Expanding research applications and growing demand for blood products are expected to create additional opportunities for suppliers of automated and advanced plasma separation technologies.
